Vac4All Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2011
NCT01341704
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

CEO, Vac4All | Vac4All